Randomized, double-blind, placebo-and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder
- Author
- YAMAGUCHI, Osamu1 ; MARUI, Eiji2 ; SEKI, Narihito10 ; YOSHIDA, Masaki11 ; KAKIZAKI, Hidehiro3 ; ITOH, Naoki4 ; YOKOTA, Takashi1 ; OKADA, Hiroshi5 ; ISHIZUKA, Osamu6 ; OZONO, Seiichiro7 ; GOTOH, Momokazu8 ; SUGIYAMA, Takahide9
[1] Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan
[2] Department of Public Health, Juntendo University School of Medicine, Tokyo, Japan
[3] Departments of Urology, Asahikawa Medical College, Hokkaido, Japan
[4] Sapporo Medical University School of Medicine, Hokkaido, Japan
[5] Teikyo University School of Medicine, Tokyo, Japan
[6] Shinshu University School of Medicine, Nagano, Japan
[7] Hamamatsu University School of Medicine, Shizuoka, Japan
[8] Nagoya University Graduate School of Medicine, Aichi, Japan
[9] Takaishi Fujii Hospital, Osaka, Japan
[10] Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
[11] Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
the Japanese Solifenacin Study Group, Japan - Source
BJU international (Papier). 2007, Vol 100, Num 3, pp 579-587, 9 p ; ref : 37 ref
- ISSN
- 1464-4096
- Scientific domain
- Urology, nephrology
- Publisher
- Blackwell, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- efficacy overactive bladder propiverine hydrochloride quality of life solifenacin succinate tolerability
- Keyword (fr)
- Chlorhydrate Dose journalière Efficacité traitement Essai clinique Homme Japonais Placebo Propivérine Qualité vie Randomisation Solifénacine Spasmolytique Urologie Vessie hyperactive Antimuscarinique Néphrologie Japon Antagoniste Appareil urinaire pathologie Parasympatholytique Récepteur cholinergique Récepteur muscarinique Vessie pathologie Voie urinaire pathologie Asie
- Keyword (en)
- Hydrochlorides Daily dose Treatment efficiency Clinical trial Human Japanese Placebo Propiverine Quality of life Randomization Solifenacin Antispasmodic agent Urology Overactive bladder Nephrology Japan Antagonist Urinary system disease Parasympatholytic Cholinergic receptor Muscarinic receptor Bladder disease Urinary tract disease Asia
- Keyword (es)
- Hidrocloruro Dosis diaria Eficacia tratamiento Ensayo clínico Hombre Japonés Placebo Propiverina Calidad vida Aleatorización Solifenacina Espasmolítico Urología Vejiga hiperactiva Nefrología Japón Antagonista Aparato urinario patología Parasimpatolítico Receptor colinérgico Receptor muscarínico Vejiga patología Vía urinaria patología Asia
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases / 002B14E Urinary system involvement in other diseases. Miscellaneous / 002B14E02 Urinary tract. Prostate gland
- Discipline
- Nephrology. Urinary tract diseases
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18977293
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.1464-410X.2007.07031.x 
https://dx.doi.org/10.1111/j.1464-410X.2007.07031.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1464-410X.2007.07031.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:162:\"Randomized, double-blind, placebo-and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder\";s:9:\"\u0000*\u0000jtitle\";s:26:\"BJU international (Papier)\";s:9:\"\u0000*\u0000stitle\";s:16:\"BJU int. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"100\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"579\";s:8:\"\u0000*\u0000epage\";s:3:\"587\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1464-4096\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"YAMAGUCHI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Osamu\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"MARUI, Eiji\";i:1;s:14:\"SEKI, Narihito\";i:2;s:15:\"YOSHIDA, Masaki\";i:3;s:18:\"KAKIZAKI, Hidehiro\";i:4;s:11:\"ITOH, Naoki\";i:5;s:15:\"YOKOTA, Takashi\";i:6;s:14:\"OKADA, Hiroshi\";i:7;s:15:\"ISHIZUKA, Osamu\";i:8;s:16:\"OZONO, Seiichiro\";i:9;s:15:\"GOTOH, Momokazu\";i:10;s:18:\"SUGIYAMA, Takahide\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:162:\"Randomized, double-blind, placebo-and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1464-410X.2007.07031.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:162:\"Randomized, double-blind, placebo-and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder\";s:9:\"\u0000*\u0000jtitle\";s:26:\"BJU international (Papier)\";s:9:\"\u0000*\u0000stitle\";s:16:\"BJU int. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"100\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"579\";s:8:\"\u0000*\u0000epage\";s:3:\"587\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1464-4096\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"YAMAGUCHI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Osamu\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"MARUI, Eiji\";i:1;s:14:\"SEKI, Narihito\";i:2;s:15:\"YOSHIDA, Masaki\";i:3;s:18:\"KAKIZAKI, Hidehiro\";i:4;s:11:\"ITOH, Naoki\";i:5;s:15:\"YOKOTA, Takashi\";i:6;s:14:\"OKADA, Hiroshi\";i:7;s:15:\"ISHIZUKA, Osamu\";i:8;s:16:\"OZONO, Seiichiro\";i:9;s:15:\"GOTOH, Momokazu\";i:10;s:18:\"SUGIYAMA, Takahide\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:162:\"Randomized, double-blind, placebo-and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1464-410X.2007.07031.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1464-410X.2007.07031.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:162:\"Randomized, double-blind, placebo-and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder\";s:9:\"\u0000*\u0000jtitle\";s:26:\"BJU international (Papier)\";s:9:\"\u0000*\u0000stitle\";s:16:\"BJU int. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"100\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"579\";s:8:\"\u0000*\u0000epage\";s:3:\"587\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1464-4096\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"YAMAGUCHI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Osamu\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"MARUI, Eiji\";i:1;s:14:\"SEKI, Narihito\";i:2;s:15:\"YOSHIDA, Masaki\";i:3;s:18:\"KAKIZAKI, Hidehiro\";i:4;s:11:\"ITOH, Naoki\";i:5;s:15:\"YOKOTA, Takashi\";i:6;s:14:\"OKADA, Hiroshi\";i:7;s:15:\"ISHIZUKA, Osamu\";i:8;s:16:\"OZONO, Seiichiro\";i:9;s:15:\"GOTOH, Momokazu\";i:10;s:18:\"SUGIYAMA, Takahide\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:162:\"Randomized, double-blind, placebo-and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1464-410X.2007.07031.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:162:\"Randomized, double-blind, placebo-and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder\";s:9:\"\u0000*\u0000jtitle\";s:26:\"BJU international (Papier)\";s:9:\"\u0000*\u0000stitle\";s:16:\"BJU int. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"100\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"579\";s:8:\"\u0000*\u0000epage\";s:3:\"587\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1464-4096\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"YAMAGUCHI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Osamu\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"MARUI, Eiji\";i:1;s:14:\"SEKI, Narihito\";i:2;s:15:\"YOSHIDA, Masaki\";i:3;s:18:\"KAKIZAKI, Hidehiro\";i:4;s:11:\"ITOH, Naoki\";i:5;s:15:\"YOKOTA, Takashi\";i:6;s:14:\"OKADA, Hiroshi\";i:7;s:15:\"ISHIZUKA, Osamu\";i:8;s:16:\"OZONO, Seiichiro\";i:9;s:15:\"GOTOH, Momokazu\";i:10;s:18:\"SUGIYAMA, Takahide\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:162:\"Randomized, double-blind, placebo-and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1464-410X.2007.07031.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:162:\"Randomized, double-blind, placebo-and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder\";s:9:\"\u0000*\u0000jtitle\";s:26:\"BJU international (Papier)\";s:9:\"\u0000*\u0000stitle\";s:16:\"BJU int. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"100\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"579\";s:8:\"\u0000*\u0000epage\";s:3:\"587\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1464-4096\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"YAMAGUCHI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Osamu\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"MARUI, Eiji\";i:1;s:14:\"SEKI, Narihito\";i:2;s:15:\"YOSHIDA, Masaki\";i:3;s:18:\"KAKIZAKI, Hidehiro\";i:4;s:11:\"ITOH, Naoki\";i:5;s:15:\"YOKOTA, Takashi\";i:6;s:14:\"OKADA, Hiroshi\";i:7;s:15:\"ISHIZUKA, Osamu\";i:8;s:16:\"OZONO, Seiichiro\";i:9;s:15:\"GOTOH, Momokazu\";i:10;s:18:\"SUGIYAMA, Takahide\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:162:\"Randomized, double-blind, placebo-and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
